These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5993466)

  • 1. [Attempt of evaluation of sordinol in treatment of chronic paranoid schizophrenia].
    Grabowski K; Sujecka-Szymkiewicz H
    Neurol Neurochir Psychiatr Pol; 1966 Oct; 16(10):1179-83. PubMed ID: 5993466
    [No Abstract]   [Full Text] [Related]  

  • 2. [Long-term treatment with flupenthixol. Experiences over a 3-year period].
    Rimestad S
    Nord Med; 1967 Nov; 78(46):1514-8. PubMed ID: 6065207
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical evaluation in 112 psychiatric patients of a butyrophenone neuroleptic, dehydrobenzperidol (R 4749). A controlled study in 45 patients of dehydrobenzperidol versus haloperidol.
    Cocito E; Ambrosini G; Arata A; Bevilacqua P; Tortora E
    Arzneimittelforschung; 1970 Aug; 20(8):1119-25. PubMed ID: 4921409
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical and ambulatory experiences with fluphenazine decanoate lyogen depot in prolonged therapy of psychiatric disorders].
    Moldenhauer B
    Med Welt; 1970 Jun; 25():1150-4. PubMed ID: 5512636
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of nicotinic acid in the treatment of chronic schizophrenia].
    Maslowski J
    Psychiatr Pol; 1967; 1(3):307-11. PubMed ID: 5593258
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of haloperidol in residual schizophrenia and in the paranoid states].
    Jeri FR
    Rev Neuropsiquiatr; 1970 Jun; 33(2):114-22. PubMed ID: 5509272
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the problem of the general and elective action of psycholeptics in the therapy of schizophrenia].
    Smulevich AB; Golovan' LI; Sokolova ED; Tsutsul'kovskaia MIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(2):246-50. PubMed ID: 5655743
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug therapy of thought disorder in chronic paranoid schizophrenia: a longitudinal study.
    Wilson IC; Paulson GW; Sandifer MG
    Dis Nerv Syst; 1968 Aug; 29(8):550-1. PubMed ID: 4877898
    [No Abstract]   [Full Text] [Related]  

  • 9. [Importance of trifluoperazine in the process of social readaptation in cases of chronic schizophrenia].
    Cieślik Z; Leczycka K; Thille Z; Trembla K
    Psychiatr Pol; 1969; 3(3):333-9. PubMed ID: 4896422
    [No Abstract]   [Full Text] [Related]  

  • 10. [The use of teperin in psychotherapy].
    Saághy M
    Orv Hetil; 1971 Nov; 112(47):2836-8. PubMed ID: 4400561
    [No Abstract]   [Full Text] [Related]  

  • 11. [Information-statistical studies on the structure of simple response sequences in endogenous psychoses].
    Axmacher I; Bente D; Ferner U
    Arzneimittelforschung; 1970 Jul; 20(7):919-21. PubMed ID: 5536060
    [No Abstract]   [Full Text] [Related]  

  • 12. A clinical evaluation of prolixin enanthate.
    Goldberg HL; DiMascio A; Chaudhary B
    Psychosomatics; 1970; 11(3):173-7. PubMed ID: 5427131
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute paranoid schizophrenia. (Treatment with chlorpromazine, trifluoperazine and placebo).
    Reardon JD; Abrams S
    Dis Nerv Syst; 1966 Apr; 27(4):265-70. PubMed ID: 5936140
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of paranoid schizophrenics with chlorpromazine and group therapy.
    Borowski T; Tolwinski T
    Dis Nerv Syst; 1969 Mar; 30(3):201-2. PubMed ID: 5774344
    [No Abstract]   [Full Text] [Related]  

  • 15. Qualitative and quantitative EEG changes of intramuscular thiothixene and trifluoperazine in chronic schizophrenia.
    Akpinar S; Itil TM; Holden JM; Hsu W
    Dis Nerv Syst; 1972 Jan; 33(1):40-5. PubMed ID: 5059688
    [No Abstract]   [Full Text] [Related]  

  • 16. Psychopharmacology and psychopathology.
    Cole JO
    Proc Annu Meet Am Psychopathol Assoc; 1969; 58():253-65. PubMed ID: 4898738
    [No Abstract]   [Full Text] [Related]  

  • 17. Aletamine in hospitalized schizophrenic patients--negative report.
    Nachand DW; Kurland AA; Hanlon TE
    J Clin Pharmacol J New Drugs; 1967; 7(2):116-7. PubMed ID: 5339906
    [No Abstract]   [Full Text] [Related]  

  • 18. [Initial results of clinical trial of a new long-acting neuroleptic agent: Fluspirelene].
    Ciccarelli G; Nosè F
    Minerva Med; 1971 Dec; 62(98):4922-7. PubMed ID: 5141918
    [No Abstract]   [Full Text] [Related]  

  • 19. Thiothixene in the treatment of paranoid psychoses.
    Medvecký J; Safko S; Medvecká E
    Act Nerv Super (Praha); 1972; 14(2):92-3. PubMed ID: 5040179
    [No Abstract]   [Full Text] [Related]  

  • 20. [Target syndromes and reaction spectra of psychopharmaceuticals. Problems in therapy and research].
    Pöldinger W
    Psychiatr Neurol Med Psychol Beih; 1975; 20-21():104-9. PubMed ID: 829606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.